The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.

Eitemau Tebyg

• Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.
  gan: Rosenwirth, B, et al.
  Cyhoeddwyd: (1994)
• Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.
  gan: Billich, A, et al.
  Cyhoeddwyd: (1995)
• Functional domains of the capsid protein of human immunodeficiency virus type 1.
  gan: Dorfman, T, et al.
  Cyhoeddwyd: (1994)
• Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence
  gan: Bukovsky, Anatoly A., et al.
  Cyhoeddwyd: (1997)
• Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.
  gan: Colgan, J, et al.
  Cyhoeddwyd: (1996)